Short answer: Illinois’s list of medical cannabis qualifying conditions is set by the Illinois Department of Public Health (IDPH) and defined in 410 ILCS 130/10(h), the definition section of the Compassionate Use of Medical Cannabis Program Act. The list has three parts: a named list of debilitating conditions, terminal illness with a diagnosis of 6 months or less, and any other debilitating condition or its treatment that IDPH adds by rule. IDPH’s list was last updated August 14, 2026.
This page covers which conditions qualify and what the rules around them say. For the application steps, fees and forms, use our Illinois medical marijuana card guide. For how Illinois compares with other states, see how state medical cannabis card programs differ. HealthDataConsortium.org is a publisher, not a clinic or a government office.

Which conditions qualify in Illinois?
IDPH publishes its list on the IDPH debilitating conditions list, last updated August 14, 2026. The statute text in 410 ILCS 130/10(h) is the legal definition. The two are not worded identically, so the table shows both. The left column is IDPH’s wording. The right column is the statute’s wording.
| IDPH list (debilitating conditions page) | Statute wording (410 ILCS 130/10(h)) |
|---|---|
| Autism | autism |
| Agitation of Alzheimer’s disease | agitation of Alzheimer’s disease |
| HIV/AIDS | positive status for human immunodeficiency virus, acquired immune deficiency syndrome |
| Amyotrophic lateral sclerosis (ALS) | amyotrophic lateral sclerosis |
| Anorexia nervosa | anorexia nervosa |
| Arnold-Chiari malformation | Arnold-Chiari malformation and Syringomyelia |
| Cancer | cancer |
| Cachexia/wasting syndrome | cachexia/wasting syndrome |
| Causalgia | Causalgia |
| Chronic inflammatory demyelinating polyneuropathy | Chronic Inflammatory Demyelinating Polyneuropathy |
| Chronic pain | chronic pain |
| Crohn’s disease | Crohn’s disease (including, but not limited to, ulcerative colitis) |
| CRPS (complex regional pain syndrome Type II) | CRPS (Complex Regional Pain Syndromes Type II) |
| Dystonia | Dystonia |
| Ehlers-Danlos syndrome | Ehlers-Danlos Syndrome |
| Endometriosis | endometriosis |
| Female orgasmic disorder | female orgasmic disorder |
| Fibrous dysplasia | fibrous dysplasia |
| Glaucoma | glaucoma |
| Hepatitis C | hepatitis C |
| Hydrocephalus | Hydrocephalus |
| Hydromyelia | Named in the spinal cord disease entry below |
| Interstitial cystitis | Interstitial Cystitis |
| Irritable bowel syndrome | irritable bowel syndrome |
| Lupus | Lupus |
| Migraines | migraines |
| Multiple sclerosis | Multiple Sclerosis |
| Muscular dystrophy | muscular dystrophy |
| Myasthenia gravis | Myasthenia Gravis |
| Myoclonus | Myoclonus |
| Nail-patella syndrome | nail-patella syndrome |
| Neuro-Bechet’s autoimmune disease | Neuro-Behcet’s Autoimmune Disease |
| Neurofibromatosis | Neurofibromatosis |
| Neuropathy | neuropathy |
| Osteoarthritis | osteoarthritis |
| Ovarian cysts | ovarian cysts |
| Parkinson’s disease | Parkinson’s |
| Polycystic kidney disease (PKD) | polycystic kidney disease |
| Polyendocrine Metabolic Ovarian Syndrome (PMOS) with Chronic Pain | See the note below the table |
| Post-concussion syndrome | traumatic brain injury and post-concussion syndrome |
| Post-traumatic stress disorder (PTSD) | post-traumatic stress disorder (PTSD) |
| Reflex sympathetic dystrophy | Reflex Sympathetic Dystrophy, RSD (Complex Regional Pain Syndromes Type I) |
| Residual limb pain | residual limb pain |
| Rheumatoid arthritis | Rheumatoid arthritis |
| Seizures (including those characteristic of epilepsy) | seizures (including those characteristic of epilepsy) |
| Severe fibromyalgia | fibromyalgia |
| Sickle Cell Disease | See the note below the table |
| Sjögren’s syndrome | Sjogren’s syndrome |
| Spinal cord disease (including but not limited to arachnoiditis) | spinal cord disease, including but not limited to arachnoiditis, Tarlov cysts, hydromyelia, syringomyelia |
| Spinal cord injury is damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity | spinal cord injury |
| Spinocerebellar ataxia | Spinocerebellar Ataxia (SCA) |
| Superior canal dehiscence syndrome | superior canal dehiscence syndrome |
| Syringomyelia | Arnold-Chiari malformation and Syringomyelia |
| Tarlov cysts | Named in the spinal cord disease entry above |
| Tourette syndrome | Tourette’s |
| Traumatic brain injury | traumatic brain injury and post-concussion syndrome |
| Ulcerative colitis | Named in the Crohn’s disease entry above |
| Uterine fibroids | uterine fibroids |
| Terminal illness (IDPH petition page: ‘Terminal illness is now a qualifying condition.’) | terminal illness with a diagnosis of 6 months or less |
Where the two wordings differ
- Sickle Cell Disease and Polyendocrine Metabolic Ovarian Syndrome (PMOS) with Chronic Pain: the statute section at 410 ILCS 130/10(h) does not show either one, while IDPH’s list includes both. Ask IDPH how each was added if either one applies to you.
- Spinal cord injury: IDPH’s list describes it as damage with objective neurological indication of intractable spasticity. The statute at 410 ILCS 130/10(h) says only ‘spinal cord injury’.
- Severe fibromyalgia: IDPH’s list says ‘Severe fibromyalgia’. The statute says ‘fibromyalgia’.
- Ulcerative colitis: IDPH’s list gives it its own line. The statute names it inside the Crohn’s disease entry, as ‘(including, but not limited to, ulcerative colitis)’.
- Spinal cord disease: the statute groups arachnoiditis, Tarlov cysts, hydromyelia and syringomyelia under one phrase, ‘spinal cord disease, including but not limited to arachnoiditis, Tarlov cysts, hydromyelia, syringomyelia’. IDPH lists several of them on separate lines.
- The statute ends its named list with ‘or the treatment of these conditions’.
A listed condition is legal access to the program, not proof that cannabis helps it.
Can I get a medical marijuana card in Illinois for anxiety?
Anxiety is not named on IDPH’s list or in the statute’s list in 410 ILCS 130/10(h). Post-traumatic stress disorder (PTSD) is named in both. Under 410 ILCS 130/10(h)(2), a condition outside the named list can be added only when IDPH adds it by rule, and the process for that is described below. The separate IDPH Opioid Alternative Patient Program page covers a different route, for a medical condition for which an opioid has been or could be prescribed.
What are the requirements to qualify in Illinois?
Under 410 ILCS 130/10(t), a qualifying patient is a person who has been diagnosed by a certifying health care professional as having a debilitating medical condition. The certification itself is set out in 410 ILCS 130/10(y). A written certification is a document dated and signed by the certifying health care professional. It must state that you have a debilitating medical condition and name it, and that the clinician is treating or managing treatment of that condition.
The statute also sets how the certification is made. It says a written certification ‘shall be made only in the course of a bona fide health care professional-patient relationship’. The clinician must complete an assessment of your medical history, review relevant records related to your condition, and conduct a physical examination.
Physicians, advanced practice registered nurses and physician assistants can certify, under 410 ILCS 130/10(d-5). A physician must be licensed under the Medical Practice Act of 1987 and hold a controlled substances license under Article III of the Illinois Controlled Substances Act (410 ILCS 130/10(s)). The same controlled substances license requirement applies to advanced practice registered nurses and physician assistants under 410 ILCS 130/10(a-5) and (s-1).
Your next step is to ask a certifying clinician whether your condition fits the list and whether they can take on the ongoing care relationship the statute describes. The registration steps and fees are in the Illinois medical marijuana card guide.
Is there a separate route if my condition is not on the list?
There are two. The first is the Opioid Alternative Patient Program. The IDPH Opioid Alternative Patient Program page states these terms:
- Qualifying patients must be at least 21 years old and be a resident of Illinois.
- Licensed physicians must certify that the patient has a medical condition for which an opioid has been or could be prescribed based on generally accepted standards of care.
- Registered patients are eligible to purchase 2.5 ounces of medical cannabis every 14 days.
- Physician certifications are valid for 90 days but can be renewed.
- A $10 fee is required for each 90-day registration period.
The second route is the petition process in 410 ILCS 130/45, described in the section on how a condition gets added below.
Can a minor get a medical cannabis card in Illinois?
Yes. The IDPH minor qualifying patient page says families may choose a one-year, two-year, or three-year Medical Cannabis Registry Card for a minor with a debilitating condition. It also says a health care professional certification is required as well as a reviewing health care professional certification. A qualifying patient under 18 may identify up to three designated caregivers, at least one of whom must be the biological parent or legal guardian.
How is a new condition added to the list, and who decides?
Under 410 ILCS 130/45(a), any resident may petition IDPH to add debilitating conditions or treatments to the list. IDPH must approve or deny a petition within 180 days of its submission. If it approves one, IDPH adds the condition by rule under the Illinois Administrative Procedure Act. Under 410 ILCS 130/45(f), the Director renders the final decision on accepted petitions. The approval or denial of any petition is a final decision of the Department, subject to judicial review, and jurisdiction and venue are vested in the Circuit Court (410 ILCS 130/45(a)).
The statute says IDPH accepts petitions once a year for a one-month period it sets. The IDPH petition to add conditions page sets that window as January 1 through January 31 each year. It says petitions received outside the open period will not be reviewed and will be returned. Each petition covers one proposed condition, as 410 ILCS 130/45(c) requires.
Under 410 ILCS 130/45(d), a petition must include:
- the petition on forms provided by the Department, in the manner the Department specifies
- a specific description of the condition, including how severe the suffering is, why conventional medical therapies are not sufficient, and the proposed benefits of medical cannabis for that condition
- evidence from the medical community and other experts supporting use of medical cannabis to alleviate suffering from the condition
- letters of support from licensed health care providers knowledgeable about the condition, including, if feasible, one from a clinician with whom the petitioner has a bona fide relationship
- any additional medical, testimonial, or scientific documentation
- an electronic copy of all materials submitted
The IDPH petition page says petitions will be accepted in hard copy format as specified in its petition form, and lists dph.medicalcannabis@illinois.gov as the address for sending them. Section 45(d)(2)(G) asks for an electronic copy of all materials submitted, so check the form for both requirements before you send anything. If a petition is deficient, 410 ILCS 130/45(d)(4) lets you correct it and resubmit in the next open period.
The statute also convenes a Medical Cannabis Advisory Board of 16 members, which examines debilitating conditions that would benefit from medical use of cannabis at the call of its Chair (410 ILCS 130/45(g) and (j)).
What changed recently, and when?
- IDPH’s debilitating conditions list was last updated August 14, 2026.
- IDPH’s petition page now states: ‘Terminal illness is now a qualifying condition.’
- Terminal illness is defined as a diagnosis of 6 months or less. If the terminal illness is not one of the named conditions, the certifying clinician must identify the cause of the terminal illness on the certification form (410 ILCS 130/10(h)(1.5)).
- The statute text lists P.A. 104-463, effective 6-12-26, as its source.
Before you apply
- Check your condition against IDPH’s current debilitating conditions list, last updated August 14, 2026.
- Confirm the fee for the card length you want on IDPH’s registry card fee page before you pay. For the Opioid Alternative Patient Program, the $10 fee is for each 90-day period.
- If your condition is not on the list, ask IDPH about the petition window and the petition format before the January 1 to January 31 period.
- If you are applying for a minor, confirm that both the certification and the reviewing certification are in place.
By HealthDataConsortium.org Research Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.

